Egyptian International Pharmaceutical Industries Company Sustainability Profile
Egyptian International Pharmaceutical Industries Company, commonly known as EIPICO, is a leading player in the pharmaceutical industry, headquartered in Egypt. Established in 1980, EIPICO has made significant strides in the production of high-quality generic medications, catering to both local and international markets. With a strong operational presence across the Middle East and North Africa, EIPICO focuses on a diverse range of therapeutic areas, including antibiotics, cardiovascular drugs, and anti-diabetics. The company is renowned for its commitment to innovation and quality, utilising advanced manufacturing techniques to ensure the efficacy and safety of its products. EIPICO's dedication to excellence has positioned it as a market leader, achieving notable milestones in production capacity and regulatory compliance. With a robust portfolio of over 200 products, EIPICO continues to contribute significantly to the healthcare landscape in Egypt and beyond.
DitchCarbon Score
How does Egyptian International Pharmaceutical Industries Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Egyptian International Pharmaceutical Industries Company's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Egyptian International Pharmaceutical Industries Company's reported carbon emissions
The Egyptian International Pharmaceutical Industries Company (EIPICO), headquartered in Egypt, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, EIPICO's climate commitments and initiatives remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or contributing to sustainability efforts within the pharmaceutical industry. The lack of data may suggest an opportunity for the company to enhance its transparency and commitment to climate action in alignment with industry standards.
How Carbon Intensive is Egyptian International Pharmaceutical Industries Company's Industry?
How Carbon Intensive is Egyptian International Pharmaceutical Industries Company's Location?
Egyptian International Pharmaceutical Industries Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Egyptian International Pharmaceutical Industries Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.